Quantbot Technologies LP Invests $863,000 in National Health Investors, Inc. $NHI

Quantbot Technologies LP purchased a new position in shares of National Health Investors, Inc. (NYSE:NHI) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 11,322 shares of the real estate investment trust’s stock, valued at approximately $863,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. International Assets Investment Management LLC acquired a new position in shares of National Health Investors during the fourth quarter valued at approximately $27,000. EverSource Wealth Advisors LLC increased its position in shares of National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after purchasing an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC acquired a new position in National Health Investors in the 4th quarter valued at $33,000. Allworth Financial LP acquired a new position in National Health Investors in the 2nd quarter valued at $42,000. Finally, Advisory Services Network LLC acquired a new stake in National Health Investors during the 3rd quarter worth $65,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at National Health Investors

In other news, CEO D. Eric Mendelsohn purchased 1,500 shares of the firm’s stock in a transaction on Friday, June 5th. The shares were bought at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the purchase, the chief executive officer directly owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Robert A. Mccabe, Jr. purchased 890 shares of the stock in a transaction dated Monday, June 15th. The shares were purchased at an average price of $71.65 per share, with a total value of $63,768.50. Following the completion of the transaction, the director owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 2.70% of the stock is currently owned by company insiders.

National Health Investors Stock Performance

NYSE NHI opened at $73.31 on Thursday. The stock has a market cap of $3.60 billion, a PE ratio of 21.19, a P/E/G ratio of 3.90 and a beta of 0.51. The company has a current ratio of 6.78, a quick ratio of 6.78 and a debt-to-equity ratio of 0.81. National Health Investors, Inc. has a twelve month low of $67.94 and a twelve month high of $91.38. The stock has a fifty day simple moving average of $75.62 and a 200-day simple moving average of $78.89.

National Health Investors (NYSE:NHI) last posted its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. The company had revenue of $121.32 million for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The company’s quarterly revenue was up 1.6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Equities analysts anticipate that National Health Investors, Inc. will post 4.78 earnings per share for the current year.

National Health Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be given a dividend of $0.92 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.0%. National Health Investors’s dividend payout ratio (DPR) is presently 108.67%.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on NHI shares. Weiss Ratings cut shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Zacks Research cut shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. Truist Financial decreased their target price on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a research note on Friday, June 12th. BMO Capital Markets dropped their price target on National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research report on Monday, June 15th. Finally, Deutsche Bank Aktiengesellschaft cut their price target on National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a report on Thursday, June 25th. Five analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $83.86.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.